Assessments
About BiophysicalCheck
Overview
What Will it Tell You?
Established Science
Your Report
The Process
FAQ
Security and Privacy
Established Science
BiophysicalCheck biomarkers are routinely used by physicians to evaluate disease. Biomarker applications are rapidly expanding in every field of medicine, and BiophysicalCheck brings this new technology to patients and their physicians at an affordable price.
BiophysicalCheck biomarker panel
Why analyze or "stack" multiple biomarkers?
There may be a significant benefit in simultaneously measuring multiple biomarkers (a process also called “stacking”). For example, the most commonly used screening test for ovarian cancer is a single biomarker called CA 125. However, CA 125 only identifies Stage I ovarian cancer in 50 percent of cases. The other half of women with early stage cancer will be missed by this single test. If five additional, biologically independent tests, each of which also has an individual detection rate of only 50 percent, are stacked along with the CA 125 test, the theoretical combined detection rate of the six tests increases to 98 percent.
Source: Hematology/Oncology Clinics of North America
Volume 17. Number 4. August 2003
BiophysicalCheck is based on Biophysical’s flagship assessment, Biophysical250. The Biophysical250 was developed by an expert team of researchers and doctors who have spent years developing advanced testing technologies for hospitals, universities and pharmaceutical companies around the world. Our medical advisory board includes internationally renowned physicians and scientists from leading medical institutions.
Disclaimer: BiophysicalCheck results do not constitute a medical opinion or advice. These results are not medical care, treatment, a treatment recommendation or a diagnosis. Communication with medical professionals employed by Biophysical Corporation about the BiophysicalCheck or its results does not establish a physician-patient relationship.